High-Quality Sulfobutyl Ether Beta-Cyclodextrin Sodium Salt: Enhancing Solubility and Stability in Pharmaceutical Formulations

Discover the power of CAS 182410-00-0, a leading pharmaceutical excipient that revolutionizes drug delivery by significantly improving solubility, stability, and safety. Unlock enhanced therapeutic outcomes with our advanced cyclodextrin solutions.

Get a Quote & Sample

Advantages You'll Experience

Enhanced Solubility

Our Sulfobutyl Ether Beta-Cyclodextrin Sodium Salt dramatically increases the solubility of poorly soluble drugs, unlocking their therapeutic potential and improving bioavailability.

Improved Stability

By forming inclusion complexes, this excipient protects sensitive drug molecules from degradation, extending shelf life and maintaining efficacy.

Reduced Toxicity & Hemolysis

The inherent properties of this anionic cyclodextrin derivative help to mitigate drug-induced toxicity and reduce the risk of hemolysis, contributing to better patient outcomes.

Key Applications

Injectable Formulations

This compound is ideal for developing stable and effective injectable drug formulations, ensuring accurate and reliable drug administration.

Oral Drug Delivery

Enhance the absorption and efficacy of oral medications by utilizing the solubilizing properties of this advanced cyclodextrin derivative.

Nasal and Ocular Solutions

Its biocompatibility and solubility make it suitable for nasal and ocular drug delivery systems, improving patient comfort and treatment effectiveness.

Topical and Inhalation Therapy

Explore its use in topical applications and inhalation therapies to deliver drugs more effectively to the target sites.